Histology test reagents IDIQ
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0221D0007
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 6 $1,705,066 obligated
Award facts
- Opportunity
-
- Histology Automated H&E, IHC, and Special Staining System Pre-Solicitation · W81K0221Q0147 · Posted May 21, 2021
- Combined order value
- $1,705,066 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 96% used
- $1,774,824.38
- Maximum order
- $400,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded an indefinite-delivery contract to Roche Diagnostics Corporation on October 1, 2021, with a ceiling value of $1,774,824.38 for histology test reagents and Roche Diagnostics Ventana Medical System platforms reagents. This is a single-award contract with no set-aside designation.
Place of performance is Castleton, Indiana. The contract was issued under a pre-solicitation posted May 21, 2021, and carries an ultimate completion date of September 30, 2026.
Recent delivery orders issued under this IDIQ reflect sustained demand for Ventana platforms and reagents supporting military healthcare operations. The Defense Health Agency issued a firm fixed-price delivery order on October 1, 2025, valued at $354,964.92 for Ventana Medical System platforms (reagents and instruments) for the Department of Pathology, due September 30, 2026. Prior delivery orders under this IDIQ include a fiscal year 2025 order (Option III) from October 1, 2024, through September 30, 2025, valued at $295,532.69; a fiscal year 2024 order (Option II) from October 1, 2023, through September 30, 2024, valued at $354,964.92; and a fiscal year 2023 order from October 1, 2022, through September 30, 2023, valued at $354,964.81. All delivery orders have been firm fixed-price and without set-aside designation. The Army Medical Command also drew against this vehicle with two cost-per-test reagent orders in fiscal year 2022, each valued at $177,482.40 and completing September 30, 2022.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract W81K0221D0007?
W81K0221D0007 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on October 1, 2021.
How much is contract W81K0221D0007 worth?
Orders under W81K0221D0007 have obligated $1,705,066. W81K0221D0007's own ceiling is $1,774,824. A single order can be worth up to $400,000.
How many orders have been placed under contract W81K0221D0007?
6 orders have been placed under W81K0221D0007, the latest on October 1, 2025.
Who can order from contract W81K0221D0007?
W81K0221D0007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0221D0007 competed?
The extent of competition for W81K0221D0007 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV